Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. (IONS) — Form 144: Proposed sale of shares
About this filing
Ionis Pharmaceuticals, Inc. (IONS) filed Form 144 (proposed sale of shares) with the SEC on Oct 16, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- Devers Shannon L.
- Relationship
- Officer
- Shares to sell
- 1,357
- Market value
- $59,708.00
- Approximate sale date
- Oct 16, 2026
- Broker
- Morgan Stanley Smith Barney
- Acquired
- Oct 15, 2026 · RSUs granted under 2011 Equity Incentive Plan
More IONS filings
- 10-Q
Filed Nov 9, 2026
- 8-K
Filed Nov 9, 2026
- 8-K
Filed Oct 23, 2026
- 8-K
Filed Oct 21, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Oct 19, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.